Relmada Therapeutics' Debt Round

Relmada Therapeutics raised a round of funding on June 07, 2013.

Relmada Therapeutics (NASDAQ: RLMD) is a clinical stage biopharmaceutical company with a diversified portfolio of four products and a pipeline for the treatment of pain. Relmada's strategy focuses on …

Articles about Relmada Therapeutics' Debt Round: